Title : Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer.

Pub. Date : 1997 Jun

PMID : 9167749






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer. Epirubicin colony stimulating factor 2 Homo sapiens
2 This study has demonstrated that epirubicin can be safely administered at 2 week intervals with GM-CSF at a dose of 90 mg/m2, equivalent to the previously reported maximum tolerated dose intensity of 45 mg/m2/week. Epirubicin colony stimulating factor 2 Homo sapiens